Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra Approximately Four Years Earlier
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Meningococcal vaccine groups A B C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Pharmacodynamics
- Sponsors sanofi pasteur
- 01 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2016 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 23 Dec 2015 New trial record